| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | Director | Common Stock | 4,443 | $758,731 | $170.77 | 22 Sep 2025 | Direct |
| LIGAND PHARMACEUTICALS INC | Director | Non-Qualified Stock Option (right to buy) | 5,783 | 06 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | 22 Sep 2025 | 1 | -$19,639 | 4 | Director | 24 Sep 2025, 17:10 |
| LGND | LIGAND PHARMACEUTICALS INC | 06 Jun 2025 | 3 | -$19,926 | 4 | Director | 10 Jun 2025, 19:21 |
| LGND | LIGAND PHARMACEUTICALS INC | 14 Jun 2024 | 2 | $0 | 4 | Director | 18 Jun 2024, 21:27 |
| LGND | LIGAND PHARMACEUTICALS INC | 22 Sep 2023 | 2 | $0 | 4 | Director | 26 Sep 2023, 17:41 |
| LGND | LIGAND PHARMACEUTICALS INC | 22 Sep 2023 | 0 | $0 | 3 | Director | 25 Sep 2023, 19:12 |